Developing a metagenomic view of xenobiotic metabolism

被引:140
作者
Haiser, Henry J. [1 ]
Turnbaugh, Peter J. [1 ]
机构
[1] Harvard Univ, Ctr Syst Biol, Fac Arts & Sci, Cambridge, MA 02138 USA
基金
美国国家卫生研究院; 加拿大健康研究院;
关键词
Metagenomics; Microbiome; Microbiota; Reduction; Hydrolysis; Xenobiotics; BACTERIAL BETA-GLUCURONIDASE; IN-VITRO MODEL; INTESTINAL MICROFLORA; GUT FLORA; L-DOPA; ENTEROHEPATIC CIRCULATION; HELICOBACTER-PYLORI; CANCER DRUG; IDENTIFICATION; EQUOL;
D O I
10.1016/j.phrs.2012.07.009
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
The microbes residing in and on the human body influence human physiology in many ways, particularly through their impact on the metabolism of xenobiotic compounds, including therapeutic drugs, antibiotics, and diet-derived bioactive compounds. Despite the importance of these interactions and the many possibilities for intervention, microbial xenobiotic metabolism remains a largely underexplored component of pharmacology. Here, we discuss the emerging evidence for both direct and indirect effects of the human gut microbiota on xenobiotic metabolism, and the initial links that have been made between specific compounds, diverse members of this complex community, and the microbial genes responsible. Furthermore, we highlight the many parallels to the now well-established field of environmental bioremediation, and the vast potential to leverage emerging metagenomic tools to shed new light on these important microbial biotransformations. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:21 / 31
页数:11
相关论文
共 133 条
[1]
Abu Shamat MS, 1983, J PHARM PHARM, V35
[2]
ABUSHAMAT M, 1993, INT J PHARM, V97, P1
[3]
Comparisons of percent equol producers between prostate cancer patients and controls: Case-controlled studies of isoflavones in Japanese, Korean and American residents [J].
Akaza, H ;
Miyanaga, N ;
Takashima, N ;
Naito, S ;
Hirao, Y ;
Tsukamoto, T ;
Fujioka, T ;
Mori, M ;
Kim, WJ ;
Song, JM ;
Pantuck, AJ .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (02) :86-89
[4]
Functional metagenomics reveals diverse β-lactamases in a remote Alaskan soil [J].
Allen, Heather K. ;
Moe, Luke A. ;
Rodbumrer, Jitsupang ;
Gaarder, Andra ;
Handelsman, Jo .
ISME JOURNAL, 2009, 3 (02) :243-251
[5]
THE EXOGENOUS ORIGIN OF TRIMETHYLAMINE IN THE MOUSE [J].
ALWAIZ, M ;
MIKOV, M ;
MITCHELL, SC ;
SMITH, RL .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (02) :135-136
[6]
BACH EJ, 1964, N-S ARCH EX PATH PH, V248, P437
[7]
Susceptibility of the H2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora [J].
Basit, AW ;
Newton, JM ;
Lacey, LF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 237 (1-2) :23-33
[8]
Colonic metabolism of ranitidine: implications for its delivery and absorption [J].
Basit, AW ;
Lacey, LF .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 227 (1-2) :157-165
[9]
Intestinal Microbiota Regulate Xenobiotic Metabolism in the Liver [J].
Bjorkholm, Britta ;
Bok, Chek Mei ;
Lundin, Annelie ;
Rafter, Joseph ;
Hibberd, Martin Lloyd ;
Pettersson, Sven .
PLOS ONE, 2009, 4 (09)
[10]
DEMETHYLATION OF METHAMPHETAMINE BY INTESTINAL MICROFLORA [J].
CALDWELL, J ;
HAWKSWORTH, GM .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) :422-424